Factors associated with statin-related adverse muscular events in adult dyslipidemic outpatients (2017)
- Authors:
- USP affiliated authors: RIBEIRO, ELIANE - FCF ; DOREA, EGIDIO LIMA - HU ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF
- Unidades: FCF; HU
- DOI: 10.1590/s2175-97902017000400199
- Subjects: DISLIPIDEMIAS; FARMACOTERAPIA; INTERAÇÃO DE MEDICAMENTOS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Brazilian Journal of Pharmaceutical Sciences
- ISSN: 2175-9790
- Volume/Número/Paginação/Ano: v. 53, n. 4, p. 1-10 art. e00199, 2017
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
CASTRO, Paula Ferreira et al. Factors associated with statin-related adverse muscular events in adult dyslipidemic outpatients. Brazilian Journal of Pharmaceutical Sciences, v. 53, n. 4, p. 1-10 art. e00199, 2017Tradução . . Disponível em: https://doi.org/10.1590/s2175-97902017000400199. Acesso em: 29 set. 2024. -
APA
Castro, P. F., Ribeiro, E., Dórea, E. L., Pinto, G. A., & Hirata, R. D. C. (2017). Factors associated with statin-related adverse muscular events in adult dyslipidemic outpatients. Brazilian Journal of Pharmaceutical Sciences, 53( 4), 1-10 art. e00199. doi:10.1590/s2175-97902017000400199 -
NLM
Castro PF, Ribeiro E, Dórea EL, Pinto GA, Hirata RDC. Factors associated with statin-related adverse muscular events in adult dyslipidemic outpatients [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53( 4): 1-10 art. e00199.[citado 2024 set. 29 ] Available from: https://doi.org/10.1590/s2175-97902017000400199 -
Vancouver
Castro PF, Ribeiro E, Dórea EL, Pinto GA, Hirata RDC. Factors associated with statin-related adverse muscular events in adult dyslipidemic outpatients [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53( 4): 1-10 art. e00199.[citado 2024 set. 29 ] Available from: https://doi.org/10.1590/s2175-97902017000400199 - Factors associated with statin-related muscular adverse events in adult dyslipidemic outpatients
- Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response
- Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression
- Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response
- Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin
- Expression of inflammatory response genes in pbmc from type 2 diabetes individuals treated with simvastatin and ezetimibe
- Leptin receptor gene polymorphisms are associated with adiposity and metabolic alterations in Brazilian individuals
- CYP3A4 and CYP3A5 mRNA expression in hypercholesterolemic individuals under hypolipemiant therapy
- Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals
- Differentiation of african components of ancestry to stratify groups in a case-control study of a brazilian urban population
Informações sobre o DOI: 10.1590/s2175-97902017000400199 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
